{"id":690150,"date":"2022-09-29T07:33:37","date_gmt":"2022-09-29T11:33:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/"},"modified":"2022-09-29T07:33:37","modified_gmt":"2022-09-29T11:33:37","slug":"ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/","title":{"rendered":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">MALVERN, Pa., Sept.  29, 2022  (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (\u201cOcugen\u201d or the \u201cCompany\u201d) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines,\u00a0today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UNFGX9WnhTfzN0unFKpIcldLE4W9LKUpLLkxEV0tGApRnYuayH6BrxRLzZLhRulMYHCS43oYp7tcU5I2OzbXQaYLr5ey4UWxbJRB4TU4keM=\" rel=\"nofollow noopener\" target=\"_blank\">Chardan 6<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iYeRg8X9aKqRKeRllIg7sPDb9-tyfu7OMEOhwT19G6Z-_3XcEqc0ujC0ZPe5taQnZboFlFTV647wM5LnYrBQq6B7H6eA-cMtSqrfoGo3fcM=\" rel=\"nofollow noopener\" target=\"_blank\"><sup>th<\/sup><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FSV_macXa3xzIUZG0vhicfl-U8Mg-KvZlLZr50nUPGpQu88JoSuMwI3CEjpW7AuU1-Jj3aTbtH0eeY3NmiLDSVaBTK1zvK3LOsBTOY9tkejKv5jmNhDEQhFdF3uSbOy-A54Pr7ApwmO-dlM-wWagVA==\" rel=\"nofollow noopener\" target=\"_blank\"> Annual Genetic Medicines Conference<\/a> being held October 3-4, 2022 in New York, NY.<\/p>\n<p>Details regarding Dr. Musunuri\u2019s fireside chat are as follows:<\/p>\n<p>\n        <strong>Event:<\/strong> Chardan 6<sup>th<\/sup> Annual Genetic Medicines Conference <br \/><strong>Date:<\/strong> October 4, 2022 <br \/><strong>Time:<\/strong> 8:30 \u2013 8:55 a.m. ET<br \/><strong>Location:<\/strong> Westin Grand Central Hotel <br \/><strong>Webcast<\/strong>: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gr9zD0ogZP4VSe90Y5GUau-2YowHFJW_pIuHJLRdh3cvXD6rF8MkQyM_9CfRqRiBHb65i-WCx1lrfl1NHV_hBG3PwIE7pg5SAQ9YMsxes-HPWZph9uHF9vgWIOj6ExYaY2L81B0uTjxyOC71Y0eKvTzTsiXOiTdLI8jqbIROvtConJL5RASfsZbSuqSCmfEQziCYWyYiecTxe-_vduLqSw4z0lOuU_4T0MWReodz5CRUDkV8A-kV-ojyIpCuDazMddeBi95JPsLPqLiH_zq6748jQ7Wh6Wp4SLKxFHj0jEyADChgHVfZISvJ5bynm3VNJV4CCMEsFUlDj458JsRJrTnDjJMpsRccp3RvQ3m27QZWT4-cNNopc7ViaNCB-mzW8GkKQXP9hhcR9LsJJ-bFDvLt5tZgFBnGJgrVZaWMvvKayRWyU2l--JPsMx-AaX--JlcMOAZ11xLgXY2-_eDIVFvEafOE4StPFaAZL4T2HsxISQN-pqtv1K895TvBq5Uzk8t3NM33sE1zsJEEpuXq0L51qciTfGBK0QkYmWZWooMBsbWrODzjQ2r1C5yyBX-DQCDt4xhjg9hiy4uwvIL_b2VNTCahYsO9JYRZKdG82tNMoPPRXuDigpP3ZOee_hny\" rel=\"nofollow noopener\" target=\"_blank\">Live Fireside Chat<\/a><\/p>\n<p>A live video webcast beginning at 8:30 a.m. ET on the day of the presentation will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bHbpRk7AvHITLNohL4zN7MzemOwAsKmCQAecR8_9IEEDgxtvmhSqfpV3MTWXf3a3lVlbb_qlcKYIY1eLXtQOpQ==\" rel=\"nofollow noopener\" target=\"_blank\">events<\/a> page of the Ocugen <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NuXHvuz_yP_HA-DLgOGdOLb7x0U5R_qxGPe4Fkc4qAGbG7w3bfLHGfTn_LuJvXzKChC_B2jwgPxNJ9ZedKNARg==\" rel=\"nofollow noopener\" target=\"_blank\">investor site<\/a>. The webcast replay will be archived for 90 days following the event.<\/p>\n<p>\n        <strong>About Ocugen, Inc.<\/strong><br \/>\n        <br \/>Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient\u2019s lives through courageous innovation\u2014forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y1DAq1EW0ACxhYwYcj1osZSYr-fRLYfyk1XulQ93sTz04HKOkB-iflUR-J0GOnBMKqbmqBnnDJn0yST7wLIh0h8aUZlhIUYIvHJs87eJB-klmNhpI7AqIb1PGyuAV-InU2F1-uFc2tXvccbXGu3daYkrFMk7v2pXwCzxIr8F2xUcdwRh2SRKAEP_OJjEKM0HEyz849PEsjNV_KFs_itmboPl-L14sWNio6q7YeKbN5s=\" rel=\"nofollow noopener\" target=\"_blank\">www.ocugen.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GuHRxB8TcQqlX7igQcTPqoZ-VHTZsGrH8RVeFnRLylf9xO6GPfIbBNPKU0K7ND8qO7kdu8Wx96HAE1ZzQmdb8Ou6EDn7oLh2UrX5IGmQb97A7dxnlbxAXn6X_-VtgPWCm7RTORSYRX190E-s53dZTrDSe2O1kHzcRbldBSIa65eAsogBikv_URc6FtyvX7GPI6R5vc3nD3aT-tlSgYo0oQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nmzZKBiSrekiKOPduJWkGc_8sv8_h5G1mvpXvuCMngdo40CU-gh_hQoSjzC52dquS5rHrZCuGD8URwJWYlDCYeLBFKYfKXn-40hWO9I_aMpG0YPzKbE7GvVN4uJQWDr4ogLpNm1LrkarwS0ycggv_KC1ywzqkKxAL7x4cISjKKd8CrQDPadKt-pWjUnRfTHzarwSxd7cBBk0ev9AYljF9OLold3vBPPwfttO2CcLElbef-tqdas-GvbuTDwto524\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Cautionary Note on Forward-Looking Statements<\/strong><br \/>\n        <br \/>\n        <em>This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled \u201cRisk Factors\u201d in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.<\/em>\n      <\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Tiffany Hamilton<br \/>Head of Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L6gjbhbbPi-DjJMtcvh5QdNmkghh5wClOnZKuik9O1WcAwdMBJUlQy20LCwf88LOxQ1OgAEUBYEuAR4HJvwSTg==\" rel=\"nofollow noopener\" target=\"_blank\">IR@ocugen.com<\/a>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDk5ZTY4ZDQtNmE5OS00NzJiLWI2MjQtYTk2MDllZTk1N2JlLTExOTYwNzM=\/tiny\/Ocugen.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (\u201cOcugen\u201d or the \u201cCompany\u201d) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines,\u00a0today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the Chardan 6th Annual Genetic Medicines Conference being held October 3-4, 2022 in New York, NY. Details regarding Dr. Musunuri\u2019s fireside chat are as follows: Event: Chardan 6th Annual Genetic Medicines Conference Date: October 4, 2022 Time: 8:30 \u2013 8:55 a.m. ETLocation: Westin Grand Central Hotel Webcast: Live Fireside Chat A live video webcast beginning at 8:30 a.m. ET on the day of the presentation will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690150","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (\u201cOcugen\u201d or the \u201cCompany\u201d) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines,\u00a0today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the Chardan 6th Annual Genetic Medicines Conference being held October 3-4, 2022 in New York, NY. Details regarding Dr. Musunuri\u2019s fireside chat are as follows: Event: Chardan 6th Annual Genetic Medicines Conference Date: October 4, 2022 Time: 8:30 \u2013 8:55 a.m. ETLocation: Westin Grand Central Hotel Webcast: Live Fireside Chat A live video webcast beginning at 8:30 a.m. ET on the day of the presentation will be &hellip; Continue reading &quot;Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T11:33:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference\",\"datePublished\":\"2022-09-29T11:33:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/\"},\"wordCount\":459,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/\",\"name\":\"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\",\"datePublished\":\"2022-09-29T11:33:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk","og_description":"MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (\u201cOcugen\u201d or the \u201cCompany\u201d) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines,\u00a0today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the Chardan 6th Annual Genetic Medicines Conference being held October 3-4, 2022 in New York, NY. Details regarding Dr. Musunuri\u2019s fireside chat are as follows: Event: Chardan 6th Annual Genetic Medicines Conference Date: October 4, 2022 Time: 8:30 \u2013 8:55 a.m. ETLocation: Westin Grand Central Hotel Webcast: Live Fireside Chat A live video webcast beginning at 8:30 a.m. ET on the day of the presentation will be &hellip; Continue reading \"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-29T11:33:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference","datePublished":"2022-09-29T11:33:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/"},"wordCount":459,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/","name":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=","datePublished":"2022-09-29T11:33:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUxMyM1MTc3NzY4IzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-inc-to-present-at-chardans-6th-annual-genetic-medicines-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen, Inc. to Present at Chardan\u2019s 6th Annual Genetic Medicines Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690150"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690150\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}